- Oscar Winner ‘The Boy And The Heron’ Bound For Max As Streamer Extends Licensing Agreement With Studio Ghibli Deadline
- Miyazaki’s Oscar Winner ‘The Boy and the Heron’ Coming to Max; Streamer Renews Deal for Studio Ghibli Films Variety
- ‘The Boy and the Heron’ Headed to Max as Streamer Extends Studio Ghibli Deal Hollywood Reporter
- The Boy and the Heron Coming to Max as Studio Ghlibi Extends Deal With Streaming Platform IGN
- Miyazaki’s Boy and the Heron, Studio Ghibli movies to stream on Max for years Polygon
Tag Archives: extends
Adele signs new deal for her Las Vegas residency as she extends sell-out shows for the second time – Daily Mail
- Adele signs new deal for her Las Vegas residency as she extends sell-out shows for the second time Daily Mail
- Adele Extends Las Vegas Residency After Falling Back in Love With Performing: “These Shows Have Changed My Life” Yahoo Entertainment
- Adele Extends Las Vegas Residency with 32 New Dates Casino.Org News
- Adele announces extension of residency on Las Vegas Strip FOX5 Las Vegas
- Adele Adds 32 Dates To Las Vegas Residency: “Let’s Go One Last Time Before I Turn Into A Showgirl Forever!” Deadline
- View Full Coverage on Google News
Ordinance row: As Nitish Kumar extends support, Delhi CM Kejriwal says defeating bill in Rajya Sabha will be semi-final for 2024 polls – The Tribune India
- Ordinance row: As Nitish Kumar extends support, Delhi CM Kejriwal says defeating bill in Rajya Sabha will be semi-final for 2024 polls The Tribune India
- Nitish Kumar meets Arvind Kejriwal in bid to forge Opposition unity Deccan Herald
- Arvind Kejriwal’s Big Outreach To Opposition Leaders Amid AAP vs Centre NDTV
- Nitish Kumar Meets Kejriwal, Opposition Unity Gains Momentum With Mamata Extending Support For Cong India Today
- Kejriwal to meet Pawar, Thackeray this week to seek support against Centre’s ordinance Hindustan Times
- View Full Coverage on Google News
Men’s Volleyball Extends Win Streaks In Another Sweep of Stanford – University of Hawai’i at Manoa Athletics – University of Hawaii Athletics
- Men’s Volleyball Extends Win Streaks In Another Sweep of Stanford – University of Hawai’i at Manoa Athletics University of Hawaii Athletics
- No. 1 Hawaii men’s volleyball team repeats sweep of No. 8 Stanford Honolulu Star-Advertiser
- Card Falls to Top-Ranked Hawai’i Stanford Athletics
- Men’s Volleyball Tops Stanford For Sixth Straight Sweep – University of Hawai’i at Manoa Athletics University of Hawaii Athletics
- Hawaii men’s volleyball welcomes Thelle back with sweep of Stanford Honolulu Star-Advertiser
- View Full Coverage on Google News
Weight loss surgery extends lives, Utah study finds
Most bariatric surgery today is done via laparoscopy, said Ted Adams, the study’s lead author. (Portra, Getty Images)
Estimated read time: 7-8 minutes
SALT LAKE CITY — Weight loss surgery reduces the risk of premature death, especially from such obesity-related conditions as cancer, diabetes and heart disease, according to a new 40-year study of nearly 22,000 people who had bariatric surgery in Utah.
Compared with those of similar weight, people who underwent one of four types of weight loss surgery were 16% less likely to die from any cause, the study found. The drop in deaths from diseases triggered by obesity, such as heart disease, cancer and diabetes, was even more dramatic.
“Deaths from cardiovascular disease decreased by 29%, while deaths from various cancers decreased by 43%, which is pretty impressive,” said lead author Ted Adams, an adjunct associate professor in nutrition and integrative physiology at the University of Utah’s School of Medicine.
“There was also a huge percentage drop — a 72% decline — in deaths related to diabetes in people who had surgery compared to those who did not,” he said. One significant downside: The study also found younger people who had the surgery were at higher risk for suicide.
Supports earlier research
The study, published Wednesday in the journal Obesity, reinforces similar findings from earlier research, including a 10-year study in Sweden that found significant reductions in premature deaths, said Dr. Eduardo Grunvald, a professor of medicine and medical director of the weight management program at the University of California San Diego Health.
The Swedish study also found a significant number of people were in remission from diabetes at both two years and 10 years after surgery.
“This new research from Utah is more evidence that people who undergo these procedures have positive, beneficial long-term outcomes,” said Grunvald, who coauthored the American Gastroenterological Association’s new guidelines on obesity treatment.
The association strongly recommends patients with obesity use recently approved weight loss medications or surgery paired with lifestyle changes.
“And the key for patients is to know that changing your diet becomes more natural, more easy to do after you have bariatric surgery or take the new weight loss medications,” said Grunvald, who was not involved in the Utah study.
“While we don’t yet fully understand why, these interventions actually change the chemistry in your brain, making it much easier to change your diet afterwards.”
Obesity is a disease, too, yet we torture people with obesity by telling them it’s their fault.
–Dr. Caroline Apovian, professor of medicine at Harvard Medical School
Despite the benefits though, only 2% of patients who are eligible for bariatric surgery ever get it, often due to the stigma about obesity, said Dr. Caroline Apovian, a professor of medicine at Harvard Medical School and codirector of the Center for Weight Management and Wellness at Brigham and Women’s Hospital in Boston. Apovian was the lead author for the Endocrine Society’s clinical practice guidelines for the pharmacological management of obesity.
Insurance carriers typically cover the cost of surgery for people over 18 with a body mass index of 40 or higher, or a BMI of 35 if the patient also has a related condition such as diabetes or high blood pressure, she said.
“I see patients with a BMI of 50, and invariably I will say, ‘You’re a candidate for everything — medication, diet, exercise and surgery.’ And many tell me, ‘Don’t talk to me about surgery. I don’t want it.’ They don’t want a surgical solution to what society has told them is a failure of willpower,” she said.
“We don’t torture people who have heart disease: ‘Oh, it’s because you ate all that fast food.’ We don’t torture people with diabetes: ‘Oh, it’s because you ate all that cake.’ We tell them they have a disease, and we treat it. Obesity is a disease, too, yet we torture people with obesity by telling them it’s their fault.”
Both men and women can benefit
Most of the people who choose bariatric surgery — around 80% — are women, Adams said. One of the strengths of the new study, he said, was the inclusion of men who had undergone the procedure.
“For all-causes of death, the mortality was reduced by 14% for females and by 21% for males,” Adams said. In addition, deaths from related causes, such as heart attack, cancer and diabetes, was 24% lower for females and 22% lower for males who underwent surgery compared with those who did not, he said.
Four types of surgery performed between 1982 and 2018 were examined in the study: gastric bypass, gastric banding, gastric sleeve and duodenal switch.
Gastric bypass, developed in the late 1960s, creates a small pouch near the top of the stomach. A part of the small intestine is brought up and attached to that point, bypassing most of the stomach and the duodenum, the first part of the small intestine.
In gastric banding, an elastic band that can be tightened or loosened is placed around the top portion of the stomach, thus restricting the volume of food entering the stomach cavity. Because gastric banding is not as successful in creating long-term weight loss, the procedure “is not as popular today,” Adams said.
“The gastric sleeve is a procedure where essentially about two-thirds of the stomach is removed laparoscopically,” he said. “It takes less time to perform, and food still passes through the much-smaller stomach. It’s become a very popular option.”
The duodenal switch is typically reserved for patients who have a high BMI, Adams added. It’s a complicated procedure that combines a sleeve gastrectomy with an intestinal bypass, and is effective for type 2 diabetes, according to the Cleveland Clinic.
A serious complication
One alarming finding of the new study was a 2.4% increase in deaths by suicide, primarily among people who had bariatric surgery between the ages of 18 and 34.
“That’s because they are told that life is going to be great after surgery or medication,” said Joann Hendelman, clinical director of the National Alliance for Eating Disorders, a nonprofit advocacy group.
“All you have to do is lose weight, and people are going to want to hang out with you, people will want to be your friend, and your anxiety and depression are going to be gone,” she said. “But that’s not reality.”
In addition, there are postoperative risks and side effects associated with bariatric surgery, such as nausea, vomiting, alcoholism, a potential failure to lose weight or even weight gain, said Susan Vibbert, an advocate at Project HEAL, which provides help for people struggling with eating disorders.
“How are we defining health in these scenarios? And is there another intervention — a weight neutral intervention?” Vibbert asked.
Past research has also shown an association between suicide risk and bariatric surgery, Grunvald said, but studies on the topic are not always able to determine a patient’s mental history.
First, we as a society must consider obesity as a disease, as a biological problem, not as a moral failing.
– Dr. Eduardo Grunvald, a professor of medicine
“Did the person opt for surgery because they had some unrealistic expectations or underlying psychological disorders that were not resolved after the surgery? Or is this a direct effect somehow of bariatric surgery? We can’t answer that for sure,” he said.
Intensive presurgery counseling is typically required for all who undergo the procedure, but it may not be enough, Apovian said. She lost her first bariatric surgery patient to suicide.
“She was older, in her 40s. She had surgery and lost 150 pounds. And then she put herself in front of a bus and died because she had underlying bipolar disorder she had been self-medicating with food,” Apovian said. “We as a society use a lot of food to hide trauma. What we need in this country is more psychological counseling for everybody, not just for people who undergo bariatric surgery.”
Managing weight is a unique process for each person, a mixture of genetics, culture, environment, social stigma and personal health, experts say. There is no one solution for all.
“First, we as a society must consider obesity as a disease, as a biological problem, not as a moral failing,” Grunvald said. “That’s my first piece of advice.
“And if you believe your life is going to benefit from treatment, then consider evidence-based treatment, which studies show are surgery or medications, if you haven’t been able to successfully do it with lifestyle changes alone.”
×
Most recent Health stories
More stories you may be interested in
Weight loss surgery extends lives, study finds
CNN
—
Weight loss surgery reduces the risk of premature death, especially from such obesity-related conditions as cancer, diabetes and heart disease, according to a new 40-year study of nearly 22,000 people who had bariatric surgery in Utah.
Compared with those of similar weight, people who underwent one of four types of weight loss surgery were 16% less likely to die from any cause, the study found. The drop in deaths from diseases triggered by obesity, such as heart disease, cancer and diabetes, was even more dramatic.
“Deaths from cardiovascular disease decreased by 29%, while deaths from various cancers decreased by 43%, which is pretty impressive,” said lead author Ted Adams, an adjunct associate professor in nutrition and integrative physiology at the University of Utah’s School of Medicine.
“There was also a huge percentage drop — a 72% decline — in deaths related to diabetes in people who had surgery compared to those who did not,” he said. One significant downside: The study also found younger people who had the surgery were at higher risk for suicide.
The study, published Wednesday in the journal Obesity, reinforces similar findings from earlier research, including a 10-year study in Sweden that found significant reductions in premature deaths, said Dr. Eduardo Grunvald, a professor of medicine and medical director of the weight management program at the University of California San Diego Health.
The Swedish study also found a significant number of people were in remission from diabetes at both two years and 10 years after surgery.
“This new research from Utah is more evidence that people who undergo these procedures have positive, beneficial long-term outcomes,” said Grunvald, who coauthored the American Gastroenterological Association’s new guidelines on obesity treatment.
The association strongly recommends patients with obesity use recently approved weight loss medications or surgery paired with lifestyle changes.
“And the key for patients is to know that changing your diet becomes more natural, more easy to do after you have bariatric surgery or take the new weight loss medications,” said Grunvald, who was not involved in the Utah study.
“While we don’t yet fully understand why, these interventions actually change the chemistry in your brain, making it much easier to change your diet afterwards.”
Despite the benefits though, only 2% of patients who are eligible for bariatric surgery ever get it, often due to the stigma about obesity, said Dr. Caroline Apovian, a professor of medicine at Harvard Medical School and codirector of the Center for Weight Management and Wellness at Brigham and Women’s Hospital in Boston. Apovian was the lead author for the Endocrine Society’s clinical practice guidelines for the pharmacological management of obesity.
Insurance carriers typically cover the cost of surgery for people over 18 with a body mass index of 40 or higher, or a BMI of 35 if the patient also has a related condition such as diabetes or high blood pressure, she said.
“I see patients with a BMI of 50, and invariably I will say, ‘You’re a candidate for everything — medication, diet, exercise and surgery.’ And many tell me, ‘Don’t talk to me about surgery. I don’t want it.’ They don’t want a surgical solution to what society has told them is a failure of willpower,” she said.
“We don’t torture people who have heart disease: ‘Oh, it’s because you ate all that fast food.’ We don’t torture people with diabetes: ‘Oh, it’s because you ate all that cake.’ We tell them they have a disease, and we treat it. Obesity is a disease, too, yet we torture people with obesity by telling them it’s their fault.”
Most of the people who choose bariatric surgery — around 80% — are women, Adams said. One of the strengths of the new study, he said, was the inclusion of men who had undergone the procedure.
“For all-causes of death, the mortality was reduced by 14% for females and by 21% for males,” Adams said. In addition, deaths from related causes, such as heart attack, cancer and diabetes, was 24% lower for females and 22% lower for males who underwent surgery compared with those who did not, he said.
Four types of surgery performed between 1982 and 2018 were examined in the study: gastric bypass, gastric banding, gastric sleeve and duodenal switch.
Gastric bypass, developed in the late 1960s, creates a small pouch near the top of the stomach. A part of the small intestine is brought up and attached to that point, bypassing most of the stomach and the duodenum, the first part of the small intestine.
In gastric banding, an elastic band that can be tightened or loosened is placed around the top portion of the stomach, thus restricting the volume of food entering the stomach cavity. Because gastric banding is not as successful in creating long-term weight loss, the procedure “is not as popular today,” Adams said.
“The gastric sleeve is a procedure where essentially about two-thirds of the stomach is removed laparoscopically,” he said. “It takes less time to perform, and food still passes through the much-smaller stomach. It’s become a very popular option.”
The duodenal switch is typically reserved for patients who have a high BMI, Adams added. It’s a complicated procedure that combines a sleeve gastrectomy with an intestinal bypass, and is effective for type 2 diabetes, according to the Cleveland Clinic.
One alarming finding of the new study was a 2.4% increase in deaths by suicide, primarily among people who had bariatric surgery between the ages of 18 and 34.
“That’s because they are told that life is going to be great after surgery or medication,” said Joann Hendelman, clinical director of the National Alliance for Eating Disorders, a nonprofit advocacy group.
“All you have to do is lose weight, and people are going to want to hang out with you, people will want to be your friend, and your anxiety and depression are going to be gone,” she said. “But that’s not reality.”
In addition, there are postoperative risks and side effects associated with bariatric surgery, such as nausea, vomiting, alcoholism, a potential failure to lose weight or even weight gain, said Susan Vibbert, an advocate at Project HEAL, which provides help for people struggling with eating disorders.
“How are we defining health in these scenarios? And is there another intervention — a weight neutral intervention?” Vibbert asked.
Past research has also shown an association between suicide risk and bariatric surgery, Grunvald said, but studies on the topic are not always able to determine a patient’s mental history.
“Did the person opt for surgery because they had some unrealistic expectations or underlying psychological disorders that were not resolved after the surgery? Or is this a direct effect somehow of bariatric surgery? We can’t answer that for sure,” he said.
Intensive presurgery counseling is typically required for all who undergo the procedure, but it may not be enough, Apovian said. She lost her first bariatric surgery patient to suicide.
“She was older, in her 40s. She had surgery and lost 150 pounds. And then she put herself in front of a bus and died because she had underlying bipolar disorder she had been self-medicating with food,” Apovian said. “We as a society use a lot of food to hide trauma. What we need in this country is more psychological counseling for everybody, not just for people who undergo bariatric surgery.”
Managing weight is a unique process for each person, a mixture of genetics, culture, environment, social stigma and personal health, experts say. There is no one solution for all.
“First, we as a society must consider obesity as a disease, as a biological problem, not as a moral failing,” Grunvald said. “That’s my first piece of advice.
“And if you believe your life is going to benefit from treatment, then consider evidence-based treatment, which studies show are surgery or medications, if you haven’t been able to successfully do it with lifestyle changes alone.”
Stock Market Rally Awaits Fed Chief Powell, Key Economic Data; Apple Extends Slide
Dow Jones futures rose slightly overnight, along with S&P 500 futures and Nasdaq futures, with Fed chief Jerome Powell and the start of key economic data on tap.
X
The stock market rally closed mixed Tuesday with Apple (AAPL) once again a drag on the major indexes, along with Amazon.com (AMZN) and Tesla (TSLA). Meanwhile, Apple’s fellow Dow giants Boeing (BA), Chevron (CVX) and Goldman Sachs (GS) are near buy points.
Hewlett Packard Enterprise (HPE) and NetApp (NTAP) headlined earnings reports late Tuesday, with CrowdStrike (CRWD) and Workday (WDAY) kicking off big software reports this week.
HPE stock rose modestly in overnight trade after HPE earnings topped views. HP Enterprise stock, above its 200-day line, is working on a long cup base. NTAP stock plunged in extended action on weak NetApp revenue and guidance. WDAY stock jumped overnight on a Q3 beat and a $500 million buyback. CRWD stock dived despite beating Q3 views as subscriptions came in light and the cybersecurity firm implied a Q4 revenue miss.
On Wednesday morning, ADP will release its November employment estimate of private payrolls. The Labor Department will release job openings in the October JOLTS report. Job openings are watched closely by Fed chief Jerome Powell, who will speak Wednesday afternoon.
All that foreshadows the Fed’s favorite inflation gauge, the PCE price index, on Thursday morning, along with the November jobs report on Friday, as well as several other notable economic releases.
Investors should be cautious about opening new positions until there’s more clarity on the economy and Fed rate hike outlook. If anything they may want to be lightening positions in the very short term.
CVX stock is on IBD Leaderboard. BA stock is on SwingTrader.
Fed Chief Powell Speech
Fed Chief Jerome Powell will speak at the Brookings Institution at 1:30 p.m. ET on Wednesday. He’s expected to reinforce expectations that the central bank will shift to a 50-basis-point rate hike on Dec. 14. Markets see a 67.5% chance of a half-point move, but still a decent chance of a fifth straight Fed rate hike of 75 basis points. But he’ll also likely indicate that rate hikes will continue into 2023.
Whatever Powell says will quickly be overtaken by economic data. If inflation starts to show significant cooling and labor markets ease, even the most-hawkish Fed policymakers will favor slowing the pace of rate hikes and ending earlier than markets may expect. Hot price and employment data will stiffen the resolve of many Fed doves. Of course, the economic data in the coming days may show mixed results, or marginal improvement.
Dow Jones Futures Today
Dow Jones futures climbed slightly vs. fair value, along with S&P 500 futures. Nasdaq 100 futures rose a fraction.
The 10-year Treasury yield fell 1 basis point to 3.74%. Crude oil futures climbed slightly.
China’s official manufacturing index fell 1.2 points to 48 in November, falling further below the neutral 50 level and views for 49. The services index sank to 46.7 vs. forecasts for 48. China’s Covid lockdowns have taken a serious toll on the economy.
Remember that overnight action in Dow futures and elsewhere doesn’t necessarily translate into actual trading in the next regular stock market session.
Join IBD experts as they analyze actionable stocks in the stock market rally on IBD Live
Stock Market Rally
After Monday’s sharp selling, the stock market rally closed mixed Tuesday.
The Dow Jones Industrial Average closed just above break-even in Tuesday’s stock market trading. The S&P 500 index fell about 0.2%. The Nasdaq composite declined 0.6%. The small-cap Russell 2000 rose 0.3%.
Apple stock fell 2.1%, its third straight significant decline, as China Covid cases, lockdowns and protests weigh on the tech giant. On Tuesday, shares fell 2.6%, below their 50-day moving average. Above the 50-day line looms 200-day resistance for AAPL stock. Apple has seen unrest at a massive Foxconn iPhone assembly factory in China.
Amazon stock declined 1.6% and Tesla stock fell 1.1%, both retreating from near their 21-day lines. Both are relatively close to bear market lows.
U.S. crude oil prices climbed 2.4% to $79.62 a barrel. Intraday Monday, crude oil futures hit their lowest levels of the year.
The 10-year Treasury yield rose 5 basis points to 3.75%.
ETFs
Among the best ETFs, the Innovator IBD 50 ETF (FFTY) dipped 0.2%, while the Innovator IBD Breakout Opportunities ETF (BOUT) rose 0.5%. The iShares Expanded Tech-Software Sector ETF (IGV) sank 0.8%. The VanEck Vectors Semiconductor ETF (SMH) fell 0.3%.
SPDR S&P Metals & Mining ETF (XME) gained 2.3% and the Global X U.S. Infrastructure Development ETF (PAVE) 0.1%. U.S. Global Jets ETF (JETS) ascended 1.8%. The Financial Select SPDR ETF (XLF) climbed 0.6%. The Health Care Select Sector SPDR Fund (XLV) fell 0.25%.
Reflecting more-speculative story stocks, ARK Innovation ETF (ARKK) edged down 0.5% and ARK Genomics ETF (ARKG) dipped 0.4%. Tesla stock is a major holding across Ark Invest’s ETFs.
Five Best Chinese Stocks To Watch Now
Dow Stocks Near Buy Points
Boeing stock rose 2% to 175.32 on Tuesday, back above a 173.95 cup-base buy point, according to MarketSmith analysis. Shares have been trading tightly in light volume near the buy point after a big run-up on optimism for the aerospace giant. Analysts expect Boeing to return to profitability in 2023 after four years of losses. The recent pause in BA stock has the 21-day line catching up.
Chevron stock climbed 1.45% to 180.94, slightly below the 182.50 buy point and just above the 21-day line. CVX stock has been trading around that official buy point all month. An early entry near 167 on Oct. 19 was probably the safer bet initially. But with Chevron stock right at the 21-day and no longer extended from the 50-day, it’s looking more interesting.
GS stock edged up 0.35% on Tuesday to 383.71. The investment bank has a 389.68 buy point from a 35%-deep cup-with-handle base going back to November 2021. Investors also could view the recent pause as a shelf just above the buy range from a bottoming base that Goldman stock cleared in early November. The 21-day moving average is close to catching up, while the 50-day line is starting to gain ground. The relative strength line is at a multiyear high reflecting GS stock’s outperformance vs. the S&P 500.
Market Rally Analysis
The stock market rally is pulling back with key technical tests and economic data on tap, along with uncertainty over China’s Covid policies.
The S&P 500 index is extending a pullback from just below the 200-day moving average, but still above its 21-day line. The Russell 2000, which dropped back below the 200-day and 21-day lines on Monday, nudged back above the 21-day.
The laggard Nasdaq fell below the 21-day line and is closing in on its 50-day line.
Apple stock, Tesla and other megacaps have been weighing on the Nasdaq and the S&P 500 index.
The Invesco S&P 500 Equal Weight ETF (RSP) is still above its 200-day moving average.
But don’t exaggerate Apple’s impact. Many leading stocks are testing or falling below buy points or round-tripping decent gains.
The silver lining is that the stock market isn’t rallying into Fed speeches and important economic data. That could mean that markets could bounce if there are no negative surprises, with the possibility of bigger gains if upcoming headlines are positive.
But the market rally is going to do what it’s going to do.
Time The Market With IBD’s ETF Market Strategy
What To Do Now
With the markets pulling back there aren’t a whole lot of stocks flashing buy signals. Investors probably should wait for Powell’s speech and the economic data to roll in before making significant new buys. Investors may want to take at least some partial profits in winners, especially if the winning stocks are retreating back to buy points.
If the market rally revs higher soon, a large of number of stocks will look actionable. But a lot of interesting stocks today will start looking damaged if the major indexes fall significantly from here.
So investors need to stay engaged and flexible. Keep your watchlists up to date but have exit strategies for your holdings as well.
Read The Big Picture every day to stay in sync with the market direction and leading stocks and sectors.
Please follow Ed Carson on Twitter at @IBD_ECarson for stock market updates and more.
YOU MAY ALSO LIKE:
Want To Get Quick Profits And Avoid Big Losses? Try SwingTrader
Best Growth Stocks To Buy And Watch
IBD Digital: Unlock IBD’s Premium Stock Lists, Tools And Analysis Today
Tesla Vs. BYD: Which EV Giant Is The Better Buy?
NMDOH extends public health order following rise in syphilis cases
ALBUQUERQUE, N.M. – Syphilis is a disease that is easily treatable with antibiotics yet case numbers are skyrocketing across the country and in New Mexico.
That’s why the Department of Health is extending its mandate for healthcare providers to test pregnant women for the disease multiple times.
Experts say if left untreated syphilis can cause permanent damage to newborns, it can even kill them.
“I also recently heard that it was maybe a reason that wigs were very popular in certain cultures,” said Dr. Miranda Durham, medical director of the Infectious Disease Bureau.
Today, the sexually-transmitted bacterial disease doesn’t stand a chance against modern medicine.
“Penicillin is still the treatment of choice, it is an antibiotic that’s been around for a long time, and it’s really good at treating syphilis,” said Durham.
That’s why medical experts are frustrated at the increasing number of babies born with it.
CDC data says it happened more than 2,100 times in 2020. That includes 42 cases in New Mexico — the most of any state that year.
“It’s pretty alarming in a disease that really should be zero,” Durham said.
In adults, syphilis typically causes sores, rashes, and sometimes a fever.
“The most serious concern is that babies can die in utero from syphilis, and they can also die shortly after birth,” said Durham.
Experts say syphilis can also lead to serious problems in babies’ kidneys, spleens, or livers. It can even leave babies blind or deaf.
“I think the good news and all of this is just that with treatment, this is all preventable,” Durham said.
The New Mexico Department of Health recently extended a public health order mandating all healthcare providers test for the disease multiple times during a pregnancy — even if the first test comes back negative.
“You know, people have sex during pregnancy and so you can test at the beginning of pregnancy and be negative, and you can acquire syphilis along the way, and you would want to know that,” said Durham.
While it’s not guaranteed a mom will pass syphilis to her newborn, experts say there’s no reason to take that chance.
“That is really what the public health order is trying to say, don’t miss an opportunity, and don’t assume you know, that someone’s not at risk,” Durham said.
The Department of Health wants to make testing for syphilis during pregnancy a law in New Mexico.
Department representatives confirmed they are planning to reintroduce a bill in the upcoming legislative session after their first attempt failed last year.
Myanmar court extends Aung San Suu Kyi’s prison sentence to 26 years
CNN
—
A court in military-run Myanmar has sentenced Aung San Suu Kyi, the country’s deposed former leader and Nobel Peace Prize winner, to three additional years in jail for corruption, a source familiar with the case told CNN, extending her total prison term to 26 years.
Wednesday’s verdict is the latest in a string of punishments meted out against the 77-year-old, a figurehead of opposition to decades of military rule who led Myanmar for five years before being forced from power in a coup in early 2021.
Suu Kyi was found guilty of receiving $500,000 in bribes from a local tycoon, a charge she denied, according to the source. Her lawyers have said the series of crimes leveled against her are politically motivated.
Suu Kyi is currently being held in solitary confinement at a prison in the capital Naypyidaw.
Last month, Suu Kyi was found guilty of electoral fraud and sentenced to three years in prison with hard labor, in a trial related to the November 2020 general election that her National League for Democracy won in a landslide, defeating a party created by the military.
It was the first time Suu Kyi had been sentenced to hard labor since the 2021 military coup. She was given the same punishment in a separate trial under a previous administration in 2009 but that sentence was commuted.
Suu Kyi has also previously been found guilty of offenses ranging from graft to election violations.
Rights groups have repeatedly expressed concerns about the punishment of pro-democracy activists in the country since the military seized power.
Also sentenced Wednesday was Toru Kubota, 26, a Japanese journalist who received an additional three years in prison on charges of violating an immigration law, Japan’s Ministry of Foreign Affairs told CNN.
That sentence comes in addition to the 10 years Kubota received last week on charges of sedition and violating a law on electronic communications. Those charges relate to his filming of an anti-government protest in July, a Japanese diplomat said.
The ministry said the Japanese government will continue to ask Myanmar authorities to release Kubota “at the earliest possible date.”
Kubota was arrested by plainclothes police in Yangon, where he was filming a documentary that he had been working on for several years, according to a Change.org petition calling for his release.
In July, the military junta executed two prominent pro-democracy activists and two other men accused of terrorism, following a trial condemned by the UN and rights groups.
Dow Jones Futures: Nasdaq Extends Losing Streak, Enphase Shines; Apple iPhone 14 On Call
Dow Jones futures tilted lower overnight, along with S&P 500 futures and Nasdaq futures, with an Apple iPhone event in focus Wednesday. The ailing stock market rally lost more ground as Treasury yields spiked.
X
The major indexes fell further from their 50-day moving averages. The Nasdaq, extending its losing streak to seven days, undercut its late June lows intraday.
It’s not a good time to be adding exposure, but investors should look for stocks with strong relative strength. Enphase Energy (ENPH), Ulta Beauty (ULTA), Cigna (CI), Waste Connections (WCN) and Waste Management (WM) all have relative strength lines at 52-week highs. The RS line tracks a stock’s performance vs. the S&P 500 index and is an easy way to spot leaders and laggards in any kind of market. An RS line hitting a new line as, or before, a stock breaks out is especially bullish.
ENPH stock, Waste Connections and Ulta Beauty are flashing buy signals, though the market environment makes any buys risky right now.
Enphase and WCN stock are in the IBD 50. ENPH stock is in the IBD Big Cap 20.
The video embedded in this article discussed Tuesday’s market action and analyzed Enphase, Sunrun (RUN) and WCN stock.
Earnings
Chinese EV startup Nio (NIO) and sporting goods retailer Academy Sports & Outdoors (ASO) will report before Wednesday’s open. Nio stock is struggling along with most China EV makers. ASO stock is trying to hold support at its 50-day line. A strong bounce from that level could offer an early entry.
Apple iPhone Event
Apple (AAPL) will unveil the iPhone 14 and a new Apple Watch at a Wednesday event at 1 p.m. ET. The latest Apple iPhone is expected to boast incremental improvements — faster processor, better camera, and improved battery life — vs. revolutionary changes. Still, the new products are key for the holiday shopping season.
Apple stock dipped 0.8% to 154.53 after hitting resistance at the 50-day line. Shares tumbled below the 200-day and then the 50-day last week. The RS line for AAPL stock isn’t far from highs, but the market has been weakening.
Dow Jones Futures Today
Dow Jones futures edged down vs. fair value. S&P 500 futures and Nasdaq 100 futures fell 0.1%.
Remember that overnight action in Dow futures and elsewhere doesn’t necessarily translate into actual trading in the next regular stock market session.
Join IBD experts as they analyze actionable stocks in the stock market rally on IBD Live
Stock Market Rally
The stock market rally opened with modest gains but the indexes soon retreated. Despite an intraday bounce, stocks faded again.
The Dow Jones Industrial Average fell 0.55% in Tuesday’s stock market trading. The S&P 500 index declined 0.4%. The Nasdaq composite lost 0.7%. The small-cap Russell 2000 gave up 0.9%.
U.S. crude oil prices rose 1 cent from Friday’s close to $86.88 a barrel. But that’s after being up 4% Monday morning as OPEC+ unexpectedly cut production quotas slightly. Natural gas futures tumbled 7.3%, adding to Friday’s solid losses and continuing to retreat from 14-year highs. That’s despite Russia saying it won’t restore natural gas flows to Europe unless sanctions are lifted.
The 10-year Treasury yield surged 15 basis points to 3.34%, closing in on June’s 11-year high of 3.48%. The 10-year yield hit a recent low of 2.52% on Aug. 2.
Among the best ETFs, the Innovator IBD 50 ETF (FFTY) fell 1.2%. The iShares Expanded Tech-Software Sector ETF (IGV) lost 0.8%. The VanEck Vectors Semiconductor ETF (SMH) slid 1.1%.
SPDR S&P Metals & Mining ETF (XME) rose 0.7% and the Global X U.S. Infrastructure Development ETF (PAVE) edged up 0.2%. The Energy Select SPDR ETF (XLE) sank 0.9% and the Financial Select SPDR ETF (XLF) dipped 0.2%. The Health Care Select Sector SPDR Fund (XLV) inched up 0.1%
Reflecting more-speculative story stocks, ARK Innovation ETF (ARKK) retreated 1.2% and ARK Genomics ETF (ARKG) 1.8%.
Five Best Chinese Stocks To Watch Now
High RS Stocks
Enphase stock jumped 4.9% in above-average volume, rebounding from the 21-day moving average and breaking the downtrend in a short consolidation. Investors could buy ENPH stock here. It’s a top stock in the No. 1-rated Energy-Solar group, with Array Technologies (ARRY), Sunrun (RUN) and the Invesco Solar ETF (TAN) among those setting up. But any market rebound could quickly get turned back.
ENPH stock could have a flat base on a weekly chart after this week.
ULTA stock rose 1.1% to 427.82, holding above a 417.08 double-bottom buy point. Shares of the beauty products retailer have struggled to close above a prior buy point of 429.58. ULTA stock has been rangebound for the past year.
Cigna stock dipped 0.5% to 285.25, finding support around its 21-day moving average and just above its 10-week line. CI stock is just in range of a 273.67 buy point first cleared in early July. Shares of the health insurer are just above an alternate entry at 282.43. Cigna stock could be working on a three-weeks-tight pattern while a traditional base could take a couple more weeks.
Waste Management stock edged up 0.4% to 169.12. Shares hit 170.28 intraday, exactly matching a still-valid consolidation buy point, according to MarketSmith. It’s also hitting resistance at the 21-day moving average and a short downtrend. WM stock did have three declines in above-average volume last week.
Waste Connections stock broke the downtrend of a handle on Tuesday, offering an early entry. But shares closed up 0.5% to 141.30, well off intraday highs. WCN stock has a 144.56 cup-with-handle buy point. Other stocks in the highly rated Pollution Control group are faring well.
Market Rally Analysis
The Nasdaq has now fallen for seven straight sessions. So has the Russell 2000. The Dow Jones and S&P 500 have just one up day in that stretch. All are starting to lose sight of their 50-day moving averages.
Arguably the market is due for a bounce. But that wouldn’t be that meaningful.
The major indexes reclaiming their 50-day and 21-day lines would just be a first step. The 200-day moving average would be the true hurdle.
The 10-year Treasury yield jumped yet again, near long-term highs and racing higher since early August. It’s hard for stocks to withstand higher Treasury yields, especially when that also pushes the dollar higher.
Solar and pollution control stocks are among the leaders. Health insurers, energy stocks and biotechs are doing relatively well.
Time The Market With IBD’s ETF Market Strategy
What To Do Now
Investors should have minimal exposure and not look to add much exposure, if any. If you didn’t scale back much in the past couple of weeks, you might look to take profits or cut losses.
Staying largely on the sidelines until there’s real signs of market strength may mean passing up some buying opportunities, some of which may work out well. But if the market really does have legs, then there will be plenty of chances to make money. If the market jerks up and down or sells off, a high cash holding will be key.
If you can’t resist and take a position in, say, ENPH stock or Waste Connections, be aware of the elevated risks with the market struggling and the key indexes facing multiple resistance areas.
Enphase Energy and other solar names are worth watching. So are stocks with strong relative strength broadly. That is where the next round of potential leaders will likely be. So build up your watchlists with high RS stocks.
But in a tough market, relative winners can be absolute losers.
Read The Big Picture every day to stay in sync with the market direction and leading stocks and sectors.
Please follow Ed Carson on Twitter at @IBD_ECarson for stock market updates and more.
YOU MAY ALSO LIKE:
Want To Get Quick Profits And Avoid Big Losses? Try SwingTrader
Best Growth Stocks To Buy And Watch
IBD Digital: Unlock IBD’s Premium Stock Lists, Tools And Analysis Today
Tesla Vs. BYD: Which EV Giant Is The Better Buy?